Moderna Inc (MRNA_KZ)

Currency in USD
52.80
+0.28(+0.53%)
Closed·
Earnings results expected in 14 days
MRNA_KZ is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
52.7752.80
52 wk Range
25.1058.40
Key Statistics
Bid/Ask
51.00 / 57.00
Prev. Close
52.52
Open
52.77
Day's Range
52.77-52.8
52 wk Range
25.1-58.4
Volume
8
Average Vol. (3m)
64
1-Year Change
21.519%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
MRNA_KZ Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins

Moderna Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Moderna, Inc., a biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally. The company’s respiratory vaccines include spikevax, mNEXSPIKE, mRESVIA, COVID, RSV, seasonal influenza, combination, and pandemic influenza vaccine; latent vaccines comprise cytomegalovirus, epstein-barr virus, and human immunodeficiency virus vaccines; enteric viruses include norovirus; public health vaccines consist of Zika, Nipah, and Mpox vaccines; and bacterial diseases vaccines, such as lyme vaccines. It also provides oncology therapeutics, such as intismeran autogene, cancer antigen therapy, t-cell engager, and cell therapy enhancer; and rare disease products, including propionic and methylmalonic acidemia, and cystic fibrosis. It has strategic alliances and collaborations with Merck & Co., Inc; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; immatics N.V.; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; The Bill & Melinda Gates Foundation; and OpenAI. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.

Employees
4700

Compare MRNA_KZ to Peers and Sector

Metrics to compare
MRNA_KZ
Peers
Sector
Relationship
P/E Ratio
−7.4x−7.3x−0.5x
PEG Ratio
−0.330.010.00
Price / Book
2.4x2.2x2.6x
Price / LTM Sales
10.8x4.9x3.2x
Upside (Analyst Target)
-101.8%45.7%
Fair Value Upside
Unlock−3.4%4.8%Unlock
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
Feb 13, 2026
EPS / Forecast
-2.11 / -2.62
Revenue / Forecast
678M / 662.84M
EPS Revisions
Last 90 days

MRNA_KZ Income Statement

People Also Watch

195.90
COIN
+6.23%
169.81
ORCL
+4.18%
198.87
NVDA
+1.20%
456.23
MU
-2.03%
314.05
UNH
-0.04%
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.